NEW CANAAN, CT—The Board of Trustees of the Albert B. Sabin Vaccine Institute announced the election of their newest board member, Walter Orenstein, MD. Recently recruited as Professor of Medicine and Pediatrics at Emory University School of Medicine, Dr. Orenstein’s posts at Emory will include director of the Program for Vaccine Policy and Development and associate director of the Vaccine Center. Dr.
NEW CANAAN, CT— Approximately forty of the world’s leading cancer vaccine researchers will meet this week at a scientific colloquium organized by the Albert B. Sabin Vaccine Institute. Convening in think-tank sessions, they will report on the latest developments in this promising field of therapy focused on stimulation of the body’s immune system to attack existing cancerous cells.
The U.S. Government's commitment to rapidly develop biomedical countermeasures against bioterrorist threats has stimulated a tremendous boost to biodefense research, a big push to expand research resources and facilities, and a growing dedication to build a robust biodefense industry.
PHILADELPHIA, PA, December 3, 2003—Hartford, Connecticut native Peter J. Hotez, MD, PhD, FAAP claimed the 2003 Bailey K. Ashford Medal here today at the centenary meeting of the American Society of Tropical Medicine and Hygiene. Hotez is chairman of Microbiology and Tropical Medicine, The George Washington University, and senior fellow of the Albert Sabin Vaccine Institute, headquartered in New Canaan, Connecticut.
GALICIA, SPAIN—The Sabin Vaccine Institute was represented at an international gathering in La Coluña, Spain to commemorate the 200th anniversary of the departure of the Balmis-Salvany Expedition.
NEW CANAAN, CT, October 27, 2003—The Sabin Vaccine Institute announced the appointment of Nathan Tinker, PhD, as executive director of the Cancer Vaccine Consortium (CVC), a new initiative of the decade- old New Canaan-based non-profit organization. Dr. Tinker, a resident of Norwalk, will be the principal organizer of the Consortium program, which works with a growing list of biopharmaceutical companies to advance discovery of new therapies for a range of cancers. Dr.
NEW CANAAN, CT—Robert H. Abplanalp, a major sponsor of the Albert B. Sabin Vaccine Institute, died August 30 at his home in Bronxville, NY. He was 81 years old and had cancer.
Critical research shows no link between vaccines, autism
WASHINGTON, D.C.— Two recent studies released by the WASHINGTON, D.C.— Two recent studies released by the American Journal of Preventive Medicine and the
NEW CANAAN, CT—The Sabin Vaccine Institute presents its highest non-science awards on May 14 to four illustrious groundbreakers in business, social service, and academia. One is the leader of one of the world’s premier pharmaceutical companies, two are collaborators in starting an organization to benefit the nation’s medically underserved children, and a fourth is a prominent university president.